Patent 7351555 was granted and assigned to ZymoGenetics on April, 2008 by the United States Patent and Trademark Office.
Cytokines and their receptors have proven usefulness in both basic research, animal models, and as therapeutics. The present invention provides a new cytokine receptor designated as “mouse Zcytor16,” which can bind and antagonize the IL-TIF cytokine.